Literature DB >> 12631667

Genetic polymorphisms in biotransformation enzymes in Crohn's disease: association with microsomal epoxide hydrolase.

D J de Jong1, E M J van der Logt, A van Schaik, H M J Roelofs, W H M Peters, T H J Naber.   

Abstract

BACKGROUND: Mucosal biotransformation enzymes can modify toxic compounds in the gut. As chemical or oxidative stress may be involved in the aetiology of Crohn's disease, genes encoding for enzymes involved in the prevention of such stress may be candidates for genetic susceptibility to Crohn's disease. AIM: To assess the association of Crohn's disease with genetic polymorphisms in cytochrome P450 1A1, glutathione S-transferases mu-1, pi-1, and theta-1, and epoxide hydrolase.
METHODS: chi(2) square analysis was used to compare frequencies of polymorphisms between 151 patients with Crohn's disease and 149 healthy controls.
RESULTS: In patients, a genetic polymorphism in exon 3 of the microsomal epoxide hydrolase gene was distributed significantly different compared with controls (chi(2)=23.7; p<0.0001). All other polymorphisms tested were equally distributed between patients and controls.
CONCLUSIONS: Microsomal epoxide hydrolase may play a role in the pathophysiology of Crohn's disease. Furthermore, the epoxide hydrolase gene is located on chromosome 1q, close to a region previously linked to Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631667      PMCID: PMC1773587          DOI: 10.1136/gut.52.4.547

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  41 in total

1.  Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease.

Authors:  B Sido; V Hack; A Hochlehnert; H Lipps; C Herfarth; W Dröge
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

2.  Structure and organization of the microsomal xenobiotic epoxide hydrolase gene.

Authors:  C N Falany; P McQuiddy; C B Kasper
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

3.  High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers.

Authors:  N Jourenkova-Mironova; K Mitrunen; C Bouchardy; P Dayer; S Benhamou; A Hirvonen
Journal:  Cancer Res       Date:  2000-02-01       Impact factor: 12.701

4.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

5.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

6.  CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease.

Authors:  Suzanne Lesage; Habib Zouali; Jean-Pierre Cézard; Jean-Frédéric Colombel; Jacques Belaiche; Sven Almer; Curt Tysk; Colm O'Morain; Miquel Gassull; Vibeke Binder; Yigael Finkel; Robert Modigliani; Corinne Gower-Rousseau; Jeanne Macry; Françoise Merlin; Mathias Chamaillard; Anne-Sophie Jannot; Gilles Thomas; Jean-Pierre Hugot
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

7.  Human microsomal xenobiotic epoxide hydrolase. Complementary DNA sequence, complementary DNA-directed expression in COS-1 cells, and chromosomal localization.

Authors:  R C Skoda; A Demierre; O W McBride; F J Gonzalez; U A Meyer
Journal:  J Biol Chem       Date:  1988-01-25       Impact factor: 5.157

8.  In vitro antioxidant properties of potential biotransformation products of salicylate, sulphasalazine and amidopyrine.

Authors:  W H Betts; M W Whitehouse; L G Cleland; B Vernon-Roberts
Journal:  J Free Radic Biol Med       Date:  1985

9.  Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.

Authors:  J Hampe; A Cuthbert; P J Croucher; M M Mirza; S Mascheretti; S Fisher; H Frenzel; K King; A Hasselmeyer; A J MacPherson; S Bridger; S van Deventer; A Forbes; S Nikolaus; J E Lennard-Jones; U R Foelsch; M Krawczak; C Lewis; S Schreiber; C G Mathew
Journal:  Lancet       Date:  2001-06-16       Impact factor: 79.321

10.  The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease.

Authors:  Andrew P Cuthbert; Sheila A Fisher; Muddassar M Mirza; Kathy King; Jochen Hampe; Peter J P Croucher; Silvia Mascheretti; Jeremy Sanderson; Alastair Forbes; John Mansfield; Stefan Schreiber; Cathryn M Lewis; Christopher G Mathew
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

View more
  10 in total

1.  Biallelic genotype distributions in papers published in Gut between 1998 and 2003: altered conclusions after recalculating the Hardy-Weinberg equilibrium.

Authors:  B Györffy; I Kocsis; B Vásárhelyi
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

2.  No genetic association between EPHX1 and Crohn's disease.

Authors:  W H M Peters; E M J van der Logt; R H M Te Morsche; H M J Roelofs; D J de Jong; T H J Naber
Journal:  Gut       Date:  2005-07-19       Impact factor: 23.059

3.  GST Theta null genotype is associated with an increased risk for ulcerative colitis: a case-control study and meta-analysis of GST Mu and GST Theta polymorphisms in inflammatory bowel disease.

Authors:  Mark M T J Broekman; Caro Bos; René H M Te Morsche; Frank Hoentjen; Hennie M J Roelofs; Wilbert H M Peters; Geert J A Wanten; Dirk J de Jong
Journal:  J Hum Genet       Date:  2014-09-04       Impact factor: 3.172

4.  Association between the GLUT1 gene polymorphism and the risk of diabetic nephropathy: a meta-analysis.

Authors:  Elias Zintzaras; Ioannis Stefanidis
Journal:  J Hum Genet       Date:  2005-01-29       Impact factor: 3.172

5.  Association of microsomal epoxide hydrolase exon 3 Tyr113His and exon 4 His139Arg polymorphisms with gastric cancer in India.

Authors:  Ujjala Ghoshal; Sushil Kumar; Virendra Jaiswal; Shweta Tripathi; Balraj Mittal; Uday C Ghoshal
Journal:  Indian J Gastroenterol       Date:  2013-04-12

6.  The role of N-acetyltransferase 2 polymorphism in the etiopathogenesis of inflammatory bowel disease.

Authors:  M Baranska; R Trzcinski; A Dziki; M Rychlik-Sych; M Dudarewicz; J Skretkowicz
Journal:  Dig Dis Sci       Date:  2011-02-15       Impact factor: 3.199

7.  Etiological study of esophageal squamous cell carcinoma in an endemic region: a population-based case control study in Huaian, China.

Authors:  Zemin Wang; Lili Tang; Guiju Sun; Yuntian Tang; Yin Xie; Shaokang Wang; Xu Hu; Weimin Gao; Stephen B Cox; Jia-Sheng Wang
Journal:  BMC Cancer       Date:  2006-12-15       Impact factor: 4.430

8.  LPS-Stimulated Whole Blood Cytokine Production Is Not Related to Disease Behavior in Patients with Quiescent Crohn's Disease.

Authors:  Mark M T J Broekman; Hennie M J Roelofs; Frank Hoentjen; Renske Wiegertjes; Nicole Stoel; Leo A Joosten; Dirk J de Jong; Geert J A Wanten
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

9.  Association Study of Glutathione S-transferases Gene Polymorphisms (GSTM1 and GSTT1) with Ulcerative Colitis and Crohn's Disease in the South of Iran.

Authors:  Maryam Moini; Mostafa Saadat; Hooshang Saadat; Atefeh Esmailnejad; Alireza Safarpour
Journal:  Adv Biomed Res       Date:  2017-06-06

10.  Association of Glutathione S-Transferase M1 null genotype with inflammatory bowel diseases: A systematic review and meta-analysis.

Authors:  Yu-Jie Zhou; Bao-Lin Zhao; Zheng Qian; Yi Xu; Ya-Qing Ding
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.